Cognitive improvements in psychotic subjects treated with "Seroquel" (quetiapine fumarate): An exploratory study

被引：8
作者：
Fleming, K [1 ]
Thyrum, P
Yeh, C
Vargo, DL
Potkin, SG
机构：
[1] Univ Calif Irvine, Irvine, CA 92697 USA
[2] AstraZeneca Pharmaceut, Wilmington, DE USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2001年 / 21卷 / 05期
关键词：
D O I：
10.1097/00004714-200110000-00011
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：527 / 529
页数：3
相关论文
共 11 条
[1]   Multiple fixed doses of ''Seroquel'' (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo [J].
Arvanitis, LA ;
Miller, BG ;
Borison, RL ;
Pitts, WM ;
Sharif, ZA ;
Hamner, MB ;
Herz, MI ;
True, JE ;
Velligan, D ;
Knesevich, MA ;
Small, J ;
Steinbook, R ;
Hertzman, M ;
Keck, PE ;
Newcomer, JW ;
Grace, J ;
Rotrosen, J ;
Tandon, R ;
Dott, SG ;
Ferguson, JM ;
Addington, DEN ;
MacEwan, GW ;
Nair, VNP ;
Shriqui, CL ;
Williams, R ;
Daniel, DG ;
Shehi, GM ;
Patterson, WM ;
Merideth, CH .
BIOLOGICAL PSYCHIATRY, 1997, 42 (04) :233-246
[2]   Neurocognitive impairment in schizophrenia and how it affects treatment options [J].
Bilder, RM .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1997, 42 (03) :255-264
[3]   THE COMPARATIVE EFFICACY AND LONG-TERM EFFECT OF CLOZAPINE TREATMENT ON NEUROPSYCHOLOGICAL TEST-PERFORMANCE [J].
BUCHANAN, RW ;
HOLSTEIN, C ;
BREIER, A .
BIOLOGICAL PSYCHIATRY, 1994, 36 (11) :717-725
[4]   NEUROLEPTICS - EFFECTS ON NEUROPSYCHOLOGICAL FUNCTION IN CHRONIC-SCHIZOPHRENIC PATIENTS [J].
CASSENS, G ;
INGLIS, AK ;
APPELBAUM, PS ;
GUTHEIL, TG .
SCHIZOPHRENIA BULLETIN, 1990, 16 (03) :477-499
[5]  
Green MF, 1997, AM J PSYCHIAT, V154, P799
[6]   IMPROVEMENT IN COGNITIVE FUNCTIONS AND PSYCHIATRIC-SYMPTOMS IN TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS RECEIVING CLOZAPINE [J].
HAGGER, C ;
BUCKLEY, P ;
KENNY, JT ;
FRIEDMAN, L ;
UBOGY, D ;
MELTZER, HY .
BIOLOGICAL PSYCHIATRY, 1993, 34 (10) :702-712
[7]   The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients [J].
Hoff, AL ;
Faustman, WO ;
Wieneke, M ;
Espinoza, S ;
Costa, M ;
Wolkowitz, O ;
Csernansky, JG .
NEUROPSYCHOPHARMACOLOGY, 1996, 15 (04) :361-369
[8]   Risperidone versus haloperidol on secondary memory: Can newer medications aid learning? [J].
Kern, RS ;
Green, MF ;
Marshall, BD ;
Wirshing, WC ;
Wirshing, D ;
McGurk, SR ;
Marder, SR ;
Mintz, J .
SCHIZOPHRENIA BULLETIN, 1999, 25 (02) :223-232
[9]  
LEE MA, 1994, J CLIN PSYCHIAT, V55, P82
[10]   SEROQUEL - BIOCHEMICAL PROFILE OF A POTENTIAL ATYPICAL ANTIPSYCHOTIC [J].
SALLER, CF ;
SALAMA, AI .
PSYCHOPHARMACOLOGY, 1993, 112 (2-3) :285-292
12